CMPX – compass therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Compass Therapeutics to Participate in Upcoming Investor Events
Compass Therapeutics Reports 2024 Third Quarter Financial Results and Provides Corporate Update
Compass Therapeutics, Inc. (NASDAQ: CMPX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $10.00 price target on the stock.
Compass Therapeutics Presents Novel Biomarker Data Related to CTX-471 Clinical Activity at the 39th Society for Immunotherapy of Cancer (SITC) Annual Meeting [Yahoo! Finance]
Compass Therapeutics Presents Novel Biomarker Data Related to CTX-471 Clinical Activity at the 39th Society for Immunotherapy of Cancer (SITC) Annual Meeting
Form SC 13G/A Compass Therapeutics, Filed by: JANUS HENDERSON GROUP PLC
Form 10-Q Compass Therapeutics, For: Sep 30
Form 8-K Compass Therapeutics, For: Nov 12
Form EFFECT Compass Therapeutics,
Form S-3 Compass Therapeutics,
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.